| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587908 | Growth Hormone & IGF Research | 2017 | 37 Pages |
Abstract
IGF-1 and IGFBP-3 serum levels before initiation of adjuvant chemotherapy are not indicative of CTCs' presence in the blood and do not correlate with clinical outcome of women with early-stage breast cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Georgios Z. Papadakis, Dimitrios Mavroudis, Vasilios Georgoulias, John Souglakos, Athanasios K. Alegakis, George Samonis, Ulas Bagci, Antonis Makrigiannakis, Odysseas Zoras,